Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19609323rdf:typepubmed:Citationlld:pubmed
pubmed-article:19609323lifeskim:mentionsumls-concept:C0271510lld:lifeskim
pubmed-article:19609323lifeskim:mentionsumls-concept:C1835898lld:lifeskim
pubmed-article:19609323lifeskim:mentionsumls-concept:C0598034lld:lifeskim
pubmed-article:19609323lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:19609323lifeskim:mentionsumls-concept:C1527178lld:lifeskim
pubmed-article:19609323pubmed:issue9lld:pubmed
pubmed-article:19609323pubmed:dateCreated2009-9-1lld:pubmed
pubmed-article:19609323pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19609323pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19609323pubmed:abstractTextThe breast cancer 2, early onset protein (BRCA2) is central to the repair of DNA damage by homologous recombination. BRCA2 recruits the recombinase RAD51 to sites of damage, regulates its assembly into nucleoprotein filaments and thereby promotes homologous recombination. Localization of BRCA2 to nuclear foci requires its association with the partner and localizer of BRCA2 (PALB2), mutations in which are associated with cancer predisposition, as well as subtype N of Fanconi anaemia. We have determined the structure of the PALB2 carboxy-terminal beta-propeller domain in complex with a BRCA2 peptide. The structure shows the molecular determinants of this important protein-protein interaction and explains the effects of both cancer-associated truncating mutants in PALB2 and missense mutations in the amino-terminal region of BRCA2.lld:pubmed
pubmed-article:19609323pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19609323pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19609323pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19609323pubmed:languageenglld:pubmed
pubmed-article:19609323pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19609323pubmed:citationSubsetIMlld:pubmed
pubmed-article:19609323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19609323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19609323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19609323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19609323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19609323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19609323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19609323pubmed:statusMEDLINElld:pubmed
pubmed-article:19609323pubmed:monthSeplld:pubmed
pubmed-article:19609323pubmed:issn1469-3178lld:pubmed
pubmed-article:19609323pubmed:authorpubmed-author:PearlLaurence...lld:pubmed
pubmed-article:19609323pubmed:authorpubmed-author:AshworthAlanAlld:pubmed
pubmed-article:19609323pubmed:authorpubmed-author:LordChristoph...lld:pubmed
pubmed-article:19609323pubmed:authorpubmed-author:OliverAntony...lld:pubmed
pubmed-article:19609323pubmed:authorpubmed-author:SwiftSallySlld:pubmed
pubmed-article:19609323pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19609323pubmed:volume10lld:pubmed
pubmed-article:19609323pubmed:ownerNLMlld:pubmed
pubmed-article:19609323pubmed:authorsCompleteYlld:pubmed
pubmed-article:19609323pubmed:pagination990-6lld:pubmed
pubmed-article:19609323pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:meshHeadingpubmed-meshheading:19609323...lld:pubmed
pubmed-article:19609323pubmed:year2009lld:pubmed
pubmed-article:19609323pubmed:articleTitleStructural basis for recruitment of BRCA2 by PALB2.lld:pubmed
pubmed-article:19609323pubmed:affiliationCancer Research UK DNA Repair Enzymes Group, Section of Structural Biology, 237 Fulham Road, London SW3 6JB, UK. antony.oliver@icr.ac.uklld:pubmed
pubmed-article:19609323pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19609323pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:675entrezgene:pubmedpubmed-article:19609323lld:entrezgene
entrez-gene:79728entrezgene:pubmedpubmed-article:19609323lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19609323lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19609323lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19609323lld:pubmed